atomoxetine hydrochloride has been researched along with Autism Spectrum Disorder in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, F; Houghton, R; Loss, G | 1 |
| Ameis, SH; Anagnostou, E; Anderson, KK; Beswick, A; Gorman, DA; Lai, MC; Rodrigues, R; Szatmari, P | 1 |
| Biederman, J; Firmin, ES; Hoskova, B; Joshi, G; Wilens, T | 1 |
| Bloch, MH; Farhat, LC | 1 |
| Avillach, P; Feroe, AG; Greenspun, P; Gutiérrez-Sacristán, A; Kohane, IS; Mousavi, S; Surati, R; Uppal, N | 1 |
| Aman, MG; Arnold, LE; Brown, NV; Buchan-Page, KA; Corbett-Dick, P; Handen, BL; Hellings, J; Hollway, JA; Hyman, SL; Lecavalier, L; McAuliffe-Bellin, S; Pan, X; Rice, RR; Ryan, MM; Smith, T; Tumuluru, RV; Williams, C | 1 |
| Naguy, A | 1 |
| Aman, MG; Arnold, LE; Handen, BL; Hollway, J; Lecavalier, L; Pan, X; Silverman, L; Smith, T; Tumuluru, RV | 1 |
| Aman, MG; Andridge, R; Arnold, LE; Handen, B; Hollway, JA; Lecavalier, L; Mendoza-Burcham, M; Silverman, L; Smith, T; Williams, C | 1 |
| Charman, T; Findon, JL; Howes, OD; King, BH; Loth, E; McAlonan, GM; McCracken, JT; Murphy, DG; Parr, JR; Povey, C; Rogdaki, M; Santosh, P; Simonoff, E; Wallace, S; Wichers, RH | 1 |
| Anagnostou, E | 1 |
| Aman, MG; Arnold, LE; Handen, B; Hollway, J; Hyman, SL; Lecavalier, L; Ober, N; Page, K; Pan, X; Rice, R; Smith, T | 1 |
| Kirubakaran, R; Nebhinani, N; Patra, S; Viswanathan, A | 1 |
| Buitelaar, JK; Harfterkamp, M; Hoekstra, PJ; Minderaa, RB; van der Loo-Neus, G; van der Meer, D | 1 |
| Aman, MG; Arnold, LE; Brown, NV; Buchan-Page, KA; Corbett-Dick, P; Handen, BL; Hellings, J; Hollway, JA; Hurt, EA; Hyman, SL; Lecavalier, L; Levato, L; McAuliffe-Bellin, S; Mruzek, DW; Pan, X; Rice, RR; Ryan, MM; Silverman, LB; Smith, T; Tumuluru, RV | 1 |
| Aman, MG; Arnold, LE; Handen, BL; Hollway, JA; Lecavalier, L; Mendoza-Burcham, MI; Page, K; Sayre, P; Silverman, L; Smith, T; Tumuluru, R | 1 |
| Kilincaslan, A; Mukaddes, NM; Mutluer, TD; Pasabeyoglu, B; Tutkunkardas, MD | 1 |
| Aman, MG; Arnold, LE; Brown, NV; Buchan-Page, KA; Handen, BL; Hellings, J; Hollway, J; Hyman, SL; Lecavalier, L; Pan, X; Rice, RR; Silverman, LB; Smith, T; Tumuluru, R | 1 |
| Coleman, KJ; Croen, LA; Lakoma, MD; Lynch, FL; Madden, JM; Owen-Smith, AA; Qian, YX; Quinn, VP; Rusinak, D; Yau, VM | 1 |
5 review(s) available for atomoxetine hydrochloride and Autism Spectrum Disorder
| Article | Year |
|---|---|
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Stimulants; Child; Guanfacine; Humans; Methylphenidate | 2021 |
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Guanfacine; Humans; Intellectual Disability; Methylphenidate; Treatment Outcome | 2021 |
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Consensus; Guanfacine; Humans; Melatonin; Methylphenidate; Psychopharmacology; Sleep Wake Disorders | 2018 |
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depressants; Central Nervous System Stimulants; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Irritable Mood; Melatonin; Metformin; Methylphenidate; Obesity; Outcome Assessment, Health Care; Precision Medicine; Risperidone; Sleep; Sleep Wake Disorders | 2018 |
Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Female; Humans; Male; Treatment Outcome | 2019 |
7 trial(s) available for atomoxetine hydrochloride and Autism Spectrum Disorder
| Article | Year |
|---|---|
Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Appetite; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Double-Blind Method; Fatigue; Female; Humans; Male; Parents | 2017 |
Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Autism Spectrum Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Middle Aged; Parents; Stress, Psychological; Treatment Outcome | 2018 |
Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Female; Humans; Male; Parents; Sleep; Surveys and Questionnaires; Treatment Outcome | 2018 |
A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Parents; Problem Behavior; Psychiatric Status Rating Scales; Surveys and Questionnaires; Treatment Outcome | 2018 |
Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Behavior Rating Scale; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Parents; Psychiatric Status Rating Scales; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; United States | 2015 |
Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Caregivers; Child; Combined Modality Therapy; Female; Humans; Male; Parents; Personal Satisfaction; Surveys and Questionnaires; Treatment Outcome | 2016 |
Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Child, Preschool; Combined Modality Therapy; Double-Blind Method; Female; Humans; Male; Parents; Psychiatric Status Rating Scales; Surveys and Questionnaires; Treatment Outcome | 2016 |
7 other study(ies) available for atomoxetine hydrochloride and Autism Spectrum Disorder
| Article | Year |
|---|---|
Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cardiovascular Diseases; Cardiovascular System; Case-Control Studies; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Logistic Models; Male; Retrospective Studies | 2020 |
Commentary: Identifying individualized predictions of response in ADHD pharmacotherapy - a commentary on Rodrigues et al. (2020).
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Guanfacine; Humans; Methylphenidate | 2021 |
Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
Topics: Adolescent; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Bupropion; Child; Child, Preschool; Cohort Studies; Comorbidity; Data Mining; Depressive Disorder, Major; Dexmethylphenidate Hydrochloride; Dextroamphetamine; Female; Health Services Accessibility; Humans; Insurance; Lisdexamfetamine Dimesylate; Male; Managed Care Programs; Prevalence; Retrospective Studies | 2021 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Comorbidity; Cross-Sectional Studies; Guanfacine; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risperidone; Social Adjustment; Treatment Outcome | 2017 |
No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Female; Humans; Male | 2015 |
Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Female; Humans; Male; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome | 2016 |
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Autism Spectrum Disorder; Case-Control Studies; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Infant; Insurance, Health; Male; Psychotropic Drugs; United States | 2017 |